bioAffinity Technologies (BIAFW) PEG Ratio

Price: $2
Market Cap: $26.98M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 2.934
52W Range: $1.29-2.44
Website: bioAffinity Technologies

What is bioAffinity Technologies's PEG Ratio?

  • bioAffinity Technologies's trailing twelve month (TTM) PEG ratio is -0.05.
  • bioAffinity Technologies's annual PEG ratio as of today is 0.03.
  • bioAffinity Technologies's quarterly PEG ratio is 0.60.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess bioAffinity Technologies's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -1.62
    • Quarterly: -3.00
    • TTM: -2.37
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 5.08
    • Quarterly: 10.55
    • TTM: 3.36
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 2.65
    • Quarterly: 7.36
    • TTM: 6.04
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -2.13
    • Quarterly: -16.50
    • TTM: -2.95

These metrics provide insights into bioAffinity Technologies's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual PEG Ratio

0.03

Quarterly PEG Ratio

0.60

TTM PEG Ratio

-0.05

bioAffinity Technologies Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio

bioAffinity Technologies Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2023 0.03 -1.62 5.08 2.65 -2.13
2022 -0.01 -0.88 1498.72 0.65 -1.77
2021 0.74 -9.68 0.00 -3.88 -29.89
2020 -0.07 -8.42 0.00 -4.06 -27.74
2019 0.00 -18.51 0.00 -15.17 -24.59